Postoperative recurrence has become the main obstacle in prognosis of HCC patients, even after successful curative therapy. Our study analyzed the radiomics features derived from peritumoral tissue on gadoxetic acid-enhanced MR images, combined with clinical characteristics and subjective imaging findings, to evaluate their ability to preoperatively predict early recurrence of HCC after surgical resection. An AUC of 0.882 for the radiomics signature and an improved AUC of 0.926 for integrated radiomics nomogram were obtained. These results suggest that radiomics features can accurately and objectively predict early recurrence of HCCs after curative resection from preoperative MR images.
Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related death worldwide.1 Hepatic resection is recommended as the first treatment for patients with well-preserved liver function, while long-term prognosis still remains poor due to a high recurrence rate (68%-96%) within 5 years.2, 3
Qualitative radiological features reported to be predictive of early recurrence were related to peritumoral tissue, such as arterial enhancement and hypointensity on hepatobiliary phase, which suggests that imaging features involving peritumoral tissue may reveal a direct association with tumor prognosis and recurrence.4, 5 Moreover, Radiomics analysis has been proposed as a robust and effective imaging assessment method to quantify tumor phenotypic characteristics by extracting multiple quantitative features from traditional medical images.6
Texture features of peritumoral tissue based on CT images have been reported as predictors for MVI of HCC in recent studies.7, 8 However, few studies have focused on the potential ability of peritumoral radiomics features extracted from MR images in predicting early recurrence. Therefore, the aim of this study was to determine whether the peritumoral radiomics features from gadoxetic acid-enhanced MR images can predict early recurrence (<1year) in patients with hepatocellular carcinoma (HCC) after surgical resection.
1. Torre LA, Bray F, Siegel RL, et al., Global cancer statistics, 2012. CA Cancer J Clin, 2015. 65(2): p. 87-108.
2. Poon RT, Fan ST, Lo CM, et al., Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg, 2002. 235(3): p. 373-382.
3. Lau WY and Lai EC, Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int, 2008. 7(3): p. 237-257.
4. An C, Kim DW, Park YN, et al., Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection. Radiology, 2015. 276(2): p. 433-443.
5. Lee S, Kim SH, Lee JE, et al., Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol, 2017. 67(3): p. 526-534.
6. Vial A, Stirling D, Field M, et al., The role of deep learning and radiomic feature extraction in cancer-specific predictive modelling: a review. Translational Cancer Research, 2018.
7(3): p. 803-816.7. Zheng J, Chakraborty J, Chapman WC, et al.,Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis. J Am Coll Surg, 2017. 225(6): p. 778-788 e771.
8. Armato SG, Petrick NA, Chakraborty J, et al., Preoperative assessment of microvascular invasion in hepatocellular carcinoma. 2017. 10134: p. 1013410.
9. Roayaie S, Blume IN, Thung SN, et al., A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology, 2009. 137(3): p. 850-855.
10. Hu HT, Shen SL, Wang Z, et al., Peritumoral tissue on preoperative imaging reveals microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis. Abdom Radiol (NY), 2018.
11. Hui TCH, Chuah TK, Low HM, et al., Predicting early recurrence of hepatocellular carcinoma with texture analysis of preoperative MRI: a radiomics study. Clin Radiol, 2018.